SP
ABBV icon

SIH Partners’s AbbVie ABBV Stock Holding History

SIH Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Buy
+8,506
New +$1.89M 0.02% 143
2025
Q4 		– Sell
-1,831
Closed -$424K – 208
2025
Q3 		$424K Buy
+1,831
New +$373K 0.01% 172
2025
Q2 		– Sell
-16,449
Closed -$3.45M – 157
2025
Q1 		$3.45M Buy
+16,449
New +$3.2M 0.12% 64

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SIH Partners's ABBV Position: Q1 2026 in Review

SIH Partners opened a new position in AbbVie (ABBV) in Q1 2026: 8,506 shares worth $1.85M. The stake represents 0.02% of the portfolio and ranks #143 among its holdings. This is a return to the name: SIH Partners previously reported a position in ABBV as recently as Q3 2025.

SIH Partners first reported a position in ABBV in Q1 2025 and has held it in 3 quarters since. The position peaked at $3.45M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • SIH Partners held 8,506 shares of AbbVie worth $1.85M as of Q1 2026.
  • AbbVie was a new SIH Partners position in Q1 2026.
  • AbbVie made up 0.02% of SIH Partners's portfolio in Q1 2026, its #143 holding.
  • SIH Partners first reported a position in AbbVie in Q1 2025 and has held it in 3 quarters since.
  • SIH Partners's AbbVie position peaked at $3.45M in Q1 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SIH Partners's 13F filing for Q1 2026, filed 15 May 2026.